CS logo
small CS logo
Hôpital Jean-Bernard

Poitiers, France
University hospital in Poitiers
2 Rue de la Milétrie Cs 90577, 86000 Poitiers

About Hôpital Jean-Bernard


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Groupe Francophone des Myelodysplasies
8
European Organisation for Research and Treatment of Cancer - EORTC
7
UNICANCER
5
Poitiers University Hospital
2
University Hospital, Tours
2
Centre Hospitalier Universitaire, Amiens
1
Centre Oscar Lambret
1
European Society for Blood and Marrow Transplantation
1
Federation Francophone de Cancerologie Digestive
1
Gustave Roussy, Cancer Campus, Grand Paris
1
National Cancer Institute, France
1
Total Rows: 15

Clinical Trials at Hôpital Jean-Bernard


During the past decade, Hôpital Jean-Bernard conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100001100000000Started TrialsCompleted Trails201520162017201800.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
1993-03-01
Completed
Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
1993-04-01
2016-01-01
Completed
1,011
High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
1994-02-01
Completed
338
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
1995-02-01
Completed
3,300
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Surgery in Treating Patients With Neuroblastoma
1994-12-01
Unknown status
210
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1999-01-04
2007-03-31
Completed
350
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
1998-12-01
Unknown status
1,500

Rows per page:

1–34 of 34

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hôpital Jean-Bernard" #1 sponsor was "Groupe Francophone des Myelodysplasies" with 8 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "UNICANCER" with 5 trials sponsored, "Poitiers University Hospital" with 2 trials sponsored and "University Hospital, Tours" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Jean-Bernard" #1 collaborator was "Roche Pharma AG" with 5 trials as a collaborator, "Celgene Corporation" with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "SFCE" with 2 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGroupe Francophonedes Myelodysplasies: 8Groupe Francophonedes Myelodysplasies: 8European Organisationfor Research andTreatment of Cancer -EORTC: 7European Organisationfor Research andTreatment of Cancer -EORTC: 7UNICANCER: 5UNICANCER: 5Poitiers University Hospital: 2Poitiers University Hospital: 2University Hospital, Tours: 2University Hospital, Tours: 2Centre HospitalierUniversitaire, Amiens: 1Centre HospitalierUniversitaire, Amiens: 1Centre Oscar Lambret: 1Centre Oscar Lambret: 1European Society forBlood and MarrowTransplantation: 1European Society forBlood and MarrowTransplantation: 1Federation Francophonede CancerologieDigestive: 1Federation Francophonede CancerologieDigestive: 1Gustave Roussy,Cancer Campus, GrandParis: 1Gustave Roussy,Cancer Campus, GrandParis: 1

Created with Highcharts 11.1.0Top CollaboratorsRoche Pharma AG: 5Roche Pharma AG: 5Celgene Corporation: 3Celgene Corporation: 3Celgene: 2Celgene: 2SFCE: 2SFCE: 2Astellas Pharma Inc: 1Astellas Pharma Inc: 1Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1EpiCept Corporation: 1EpiCept Corporation: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1GERCOR -MultidisciplinaryOncology CooperativeGroup: 1GERCOR -MultidisciplinaryOncology CooperativeGroup: 1Johnson & JohnsonPharmaceuticalResearch &Development, L.L.C.: 1Johnson & JohnsonPharmaceuticalResearch &Development, L.L.C.: 1

Clinical Trials Conditions at Hôpital Jean-Bernard


According to Clinical.Site data, the most researched conditions in "Hôpital Jean-Bernard" are "Myelodysplastic Syndromes" (9 trials), "Leukemia" (4 trials), "Breast Cancer" (2 trials), "Lymphoma" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Hôpital Jean-Bernard" in a lesser frequency.

Clinical Trials Intervention Types at Hôpital Jean-Bernard


Most popular intervention types in "Hôpital Jean-Bernard" are "Drug" (29 trials), "Procedure" (10 trials), "Radiation" (7 trials), "Biological" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (6 trials), "cisplatin" (5 trials), "etoposide" (4 trials), "fluorouracil" (4 trials) and "Azacitidine" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Hôpital Jean-Bernard


The vast majority of trials in "Hôpital Jean-Bernard" are 30 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Hôpital Jean-Bernard


Currently, there are NaN active trials in "Hôpital Jean-Bernard". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Hôpital Jean-Bernard, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Jean-Bernard, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 15Phase 3: 15Phase 2: 13Phase 2: 13Phase 1: 3Phase 1: 3Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 22Completed: 22Unknown status: 6Unknown status: 6Terminated: 3Terminated: 3Active, not recruiting: 2Active, not recruiting: 2Withdrawn: 1Withdrawn: 1

Departments of Hôpital Jean-Bernard


Hôpital Jean-Bernard has several departments that took part in Clinical trials: "CHU Poitiers - Pôle régional de Cancérologie" - 19 trials, "Intensive reanimation" - 4 trials
Departments List
Total Rows: 2